OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 46 filers reported holding OVID THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $92,237 | -72.5% | 24,020 | -71.9% | 0.00% | – |
Q2 2021 | $335,000 | +161.7% | 85,566 | +167.0% | 0.00% | – |
Q1 2021 | $128,000 | +70.7% | 32,052 | -1.4% | 0.00% | – |
Q4 2020 | $75,000 | -50.7% | 32,492 | +23.0% | 0.00% | – |
Q3 2020 | $152,000 | -5.0% | 26,418 | +21.3% | 0.00% | – |
Q2 2020 | $160,000 | +66.7% | 21,785 | -6.0% | 0.00% | – |
Q4 2019 | $96,000 | +190.9% | 23,165 | +125.6% | 0.00% | – |
Q3 2019 | $33,000 | +450.0% | 10,269 | +208.3% | 0.00% | – |
Q2 2019 | $6,000 | -98.7% | 3,331 | -98.7% | 0.00% | – |
Q1 2019 | $454,000 | +263.2% | 257,262 | +394.4% | 0.00% | – |
Q4 2018 | $125,000 | -95.5% | 52,032 | -89.5% | 0.00% | -100.0% |
Q3 2018 | $2,795,000 | -40.9% | 493,427 | -18.6% | 0.00% | 0.0% |
Q2 2018 | $4,727,000 | +126.3% | 606,245 | +105.0% | 0.00% | 0.0% |
Q1 2018 | $2,089,000 | +0.3% | 295,722 | +40.1% | 0.00% | 0.0% |
Q4 2017 | $2,082,000 | +18.9% | 211,101 | +3.2% | 0.00% | 0.0% |
Q3 2017 | $1,751,000 | -18.8% | 204,494 | -0.6% | 0.00% | -50.0% |
Q2 2017 | $2,157,000 | – | 205,826 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TLS Advisors LLC | 1,319,679 | $5,068 | 20.50% |
Madison Avenue Partners, LP | 3,648,509 | $14,010,275 | 1.99% |
CHI Advisors LLC | 864,822 | $3,320,916 | 1.32% |
EcoR1 Capital, LLC | 6,117,400 | $23,490,816 | 0.79% |
Rubric Capital Management LP | 5,445,910 | $20,912,294 | 0.78% |
BVF INC/IL | 6,851,051 | $26,308,036 | 0.71% |
Artal Group S.A. | 2,500,000 | $9,600 | 0.41% |
DCF Advisers, LLC | 30,430 | $116,851 | 0.06% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 458,700 | $1,761,408 | 0.04% |
ACADIAN ASSET MANAGEMENT LLC | 1,701,228 | $6,531 | 0.03% |